Outpatient talc procedure for cancer-related fluid buildup
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether a talc procedure to seal the lung (pleurodesis) can be done safely in an outpatient setting for people with fluid buildup from cancer. It aims to make the treatment more convenient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a malignant pleural effusion (fluid buildup around your lung from cancer).
- You are expected to live more than 30 days.
- Your daily activity level is mostly independent (1–2, or 3 if due to shortness of breath).
- You have not had a failed pleurodesis (sealing procedure) on the same side before.
- Your lung is not known to be 'trapped' (unable to expand fully).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to stop fluid from building up again in the chest for people with cancer-related fluid buildup. One method uses a medicine called bleomycin, and the other uses a physical rubbing procedure during a scope exam. The goal is to help you breathe easier and improve your quality of life.
This study compares three ways to drain fluid that has built up around the lungs due to cancer. The goal is to find which method works best for relieving symptoms like shortness of breath.
This trial tests a new therapy using your own immune cells (called TILs) to treat cancer that has spread to the lining of the lungs. The goal is to see if these cells can shrink tumors and help you feel better.
This trial tests a drug called tocilizumab, which is given through the tube that drains fluid from your chest or belly. The goal is to see if it can help control cancer-related fluid buildup and improve symptoms.
This trial compares two ways of giving talc (a powder that helps stick the lung to the chest wall) to stop fluid or air from coming back in the chest. They will see which method is better at preventing recurrence and improving recovery.
This trial tests a new drug given directly into the chest cavity to treat fluid buildup caused by non-small cell lung cancer. It may help ease breathing problems and control the fluid.
Hear when a new Malignant Pleural Effusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.